The Male Contraceptive Initiative

-

Scientists profess that they are a step ahead to develop male contraceptive pill which will also increase libido



Drug Designing: In Melbourne researchers and scientists are developing a contraceptive pill for masculine. They are near to developing a male contraceptive version of the pill that includes the perk effect of increasing libido.
This is initiated by Dr Sab Ventura who expatiates in Drug Discovery Biology and his team say the drug blocks the transport of sperm, which is different to existing versions of the male pill which have hormonal targets or reduce the fertilization capability of sperm.
If the next stage of drug development comes out to be successful, then the pill will be in the market in coming 5-10 years following the clinical trial phases.
The scientists assert that the pill is a hormone-free formula that is set to bypass the side-effects like libido, birth defects and infertility, the ailments that have impeded the buildout of a male contraceptive.
Based on their previous research which concluded that you can produce infertility in mice by genetically omitting two proteins that trigger the transport of sperm. These proteins are the α1A-adrenoceptor and P2X1-purinoceptor.
There is already a widely-available drug approved for long-term use that targets one of the two proteins linked to the movement of sperm called Flomax.
The scientists and researchers are now striving to evolve a chemical to hinder or completely block the second protein so that a pill can be released with the combination of two. Researchers posit that it will also circumvent the aftereffects involved within the existing drugs.

For further details visit https://drug-chemistry.pharmaceuticalconferences.com/

Roza Palv
Program Manager- Pharm Chem 2018
Email: pharmaceuticalchemistry@pharmameetings.com

Comments

Post a Comment

Popular posts from this blog

Nanomedicine & Women’s Health

-
Image
Nanomedicine have the potential to revolutionize the diagnosis, prevention, and treatment of a range of conditions and diseases affecting women’s health Nanomedicine is the application of  nanotechnology  in the field of medicine with a view to enhancing the diagnosis and treatment of various diseases. Nanotechnology is already involved in a range of biomedical applications including drug and vaccine delivery, diagnostic imaging, nanosensor diagnostics, nano-enabled therapies, and tissue engineering. A growing recognition of the specific health care requirements of women has resulted in the proposed organizational changes in the provision of health care, focusing predominantly on a life course approach to women’s health care. As our understanding of the benefits of nanomaterial-based agents and diagnostics continues to grow in terms of selectivity, sensitivity, affinity, and detection limits, there is a widespread anticipation that nanotechnology will play an incre...
Read more

20th World Conference on Pharmaceutical Chemistry and Drug Design

-
Image
Drug design is an inventive process of medication discovered by biological target. It is also known as rational drug design or rational design. The drug is most commonly an organic small molecule that activates or inhibits the function of a biomolecule such as a protein, which in turn results in a therapeutic benefit to the patient. In the most basic sense. Drug design relies on the knowledge of the three-dimensional structure of bioactive sites. The drug is an active molecule, when it is predicament to target site it can either inhibit or activate the function of a biomolecule which effects in therapeutic benefit. The main objective in drug design is to foresee whether a given particle will bind to a target and if so how unequivocally. Molecular mechanics or molecular dynamics are regularly used to predict the conformation of the little particle and to model conformational changes in the biological targets that may happen when the little molecules ties to it.   Th...
Read more

Fundamentals of Drug Safety and Pharmacovigilance

-
Image
The challenge of maximizing drug safety and maintaining public confidence has become increasingly complex. Pharmaceutical and biotechnology companies must not only monitor, but also proactively assess and manage drug risk throughout a product’s lifecycle, from development to post market.   20th World Conference on Pharmaceutical Chemistry and Drug Design  is going to be held in Dubai during September 03-05 2018, under the enclosed title  "Pharmacovigilance" https://drug-chemistry.pharmaceuticalconferences.com/ Pharmacovigilance : WHO defined as 'the pharmacological science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem’ An umbrella term used to describe the processes for monitoring and evaluating ADRs is a key component of effective drug regulation systems, clinical practice and public health programs. It is the study of the safety of marketed drugs examined unde...
Read more